Hawaiʻi secures a $700 million settlement with pharmaceutical companies BMS and Sanofi, ending a 12-year lawsuit, with funds ...

The Plavix lawsuit dates back to 2014, when Hawaii first sued BMS and Sanofi, alleging that they failed to properly inform ...

Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s l | Sanofi has scrapped its ...

HPR's Ashley Mizuo reports on the settlement between two pharmaceutical companies, Sanofi and Bristol Myers Squibb in the ...

Hawaii said on Friday it entered a $700 million settlement with pharmaceutical firm Bristol-Myers Squibb and units of French ...

After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review ...

Hawaii will receive $700 million from pharmaceutical giants Bristol Myers Squibb and Sanofi in a landmark settlement over the ...

The settlement divides the $700 million payment equally between pharmaceutical giants Bristol Myers Squibb and Sanofi.

The Department of Attorney General of Hawaii announced that Bristol-Myers Squibb (NYSE:BMY) and three units of Sanofi (NASDAQ ...

Novavax posts $667 million in Q1 2025 revenue and $2.93 EPS, boosted by Sanofi payments and APA terminations; full-year ...

Sansum Diabetes Research Institute (SDRI) will host two educational programs about Type 1 diabetes (T1D). The programs will cover:• T1D and autoimmunity• ...